Complete resistance to infection in rIL-25-treated mice was associated with an early enhanced expression of terminal α-L-Fucosyl terminals (Fuc) residues in extracellular mucus and goblet cell vesicles, which is induced by IL-25 administration prior to infection. The gene discussed is IL25; the disease is infection.